KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Gross Profit (2017 - 2025)

Historic Gross Profit for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $44.2 million.

  • Cardlytics' Gross Profit fell 1805.02% to $44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.9 million, marking a year-over-year decrease of 1267.5%. This contributed to the annual value of $225.6 million for FY2024, which is 1037.81% down from last year.
  • Latest data reveals that Cardlytics reported Gross Profit of $44.2 million as of Q3 2025, which was down 1805.02% from $51.9 million recorded in Q2 2025.
  • Cardlytics' 5-year Gross Profit high stood at $75.1 million for Q4 2023, and its period low was $40.0 million during Q1 2021.
  • For the 5-year period, Cardlytics' Gross Profit averaged around $55.1 million, with its median value being $53.5 million (2024).
  • In the last 5 years, Cardlytics' Gross Profit skyrocketed by 13455.13% in 2021 and then plummeted by 1805.02% in 2025.
  • Cardlytics' Gross Profit (Quarter) stood at $71.1 million in 2021, then dropped by 7.56% to $65.7 million in 2022, then increased by 14.28% to $75.1 million in 2023, then dropped by 16.52% to $62.7 million in 2024, then dropped by 29.51% to $44.2 million in 2025.
  • Its Gross Profit was $44.2 million in Q3 2025, compared to $51.9 million in Q2 2025 and $49.1 million in Q1 2025.